The Chinese government's official news service reports that the nation is taking steps to secure its vaccine and plasma-based drug supplies. By the end of last month, its FDA equivalent, the State Food and Drug Administration, had sent over 80 supervisors to 33 plasma drug manufacturing facilities in 24 locations. For more, read on. If our FDA has a resource/workload problem, imagining what China's must contend with just boggles the mind. The brief also mentions that some of the raw materials for some plasma drugs had been "collected illegally."